VIM and neoplasm: Although vimentin is mainly found in fibroblast, endothelial cells, macrophages, and lymphocytes, collective evidence suggest that the aberrant expression of vimentin in epithelial cancer cells is related to the epithelial–mesenchymal transition (EMT) and associated with tumor initiation, invasion, metastasis, and resistance to therapy [30,31].